Avinger Inc (AVGR) Stock Price, Quote & News

Latest News on AVGR

Nov 7, 2024, 9:43 PM EST - 2 months ago

Avinger, Inc. (AVGR) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 2 months ago

Avinger Reports Third Quarter 2024 Results

Oct 29, 2024, 8:00 AM EDT - 2 months ago

Avinger to Announce Third Quarter 2024 Results on November 7, 2024

Oct 24, 2024, 8:00 AM EDT - 3 months ago

Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention

Sep 18, 2024, 8:00 AM EDT - 4 months ago

Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents

Aug 20, 2024, 8:30 AM EDT - 5 months ago

Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device

Aug 9, 2024, 12:42 PM EDT - 5 months ago

Avinger, Inc. (AVGR) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 5 months ago

Avinger Reports Second Quarter 2024 Results

Aug 5, 2024, 8:00 AM EDT - 5 months ago

Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer

Jul 29, 2024, 8:45 AM EDT - 6 months ago

Avinger to Announce Second Quarter 2024 Results on August 8, 2024

Jun 17, 2024, 4:05 PM EDT - 7 months ago

Avinger Announces Closing of up to $24 Million Public Offering

Jun 14, 2024, 8:00 AM EDT - 7 months ago

Avinger Announces Pricing of up to $24 Million Public Offering

Jun 5, 2024, 7:30 AM EDT - 8 months ago

Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business

May 16, 2024, 4:05 PM EDT - 8 months ago

Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity

May 15, 2024, 6:15 PM EDT - 8 months ago

Avinger, Inc. (AVGR) Q1 2024 Earnings Call Transcript

May 15, 2024, 4:01 PM EDT - 8 months ago

Avinger Reports First Quarter 2024 Results

May 7, 2024, 8:15 AM EDT - 9 months ago

Avinger to Announce First Quarter 2024 Results on May 15, 2024

Mar 20, 2024, 5:56 PM EDT - 10 months ago

Avinger, Inc. (AVGR) Q4 2023 Earnings Call Transcript

Mar 20, 2024, 4:05 PM EDT - 10 months ago

Avinger Reports Fourth Quarter and Full Year 2023 Results

Mar 12, 2024, 9:00 AM EDT - 11 months ago

Avinger to Announce Full Year 2023 Results on March 20, 2024

Mar 7, 2024, 2:04 AM EST - 11 months ago

Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions

Mar 6, 2024, 7:30 PM EST - 11 months ago

Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge

Oct 26, 2023, 6:23 PM EDT - 1 year ago

Avinger, Inc. (AVGR) Q3 2023 Earnings Call Transcript

Oct 26, 2023, 4:01 PM EDT - 1 year ago

Avinger Reports Third Quarter 2023 Results

Oct 19, 2023, 8:00 AM EDT - 1 year ago

Avinger to Announce Third Quarter 2023 Results on October 26

Sep 27, 2023, 8:00 AM EDT - 1 year ago

Avinger Raises $5.3 Million via At-The-Market Facility

Sep 18, 2023, 11:30 AM EDT - 1 year ago

Avinger stock rockets off a record low after launch of vascular disease treatment system

Sep 18, 2023, 8:00 AM EDT - 1 year ago

Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device

Aug 24, 2023, 8:00 AM EDT - 1 year ago

Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023

Aug 4, 2023, 9:00 AM EDT - 1 year ago

Avinger Announces Conversion of 12% of CRG Term Debt into Equity

Jul 27, 2023, 9:54 PM EDT - 1 year ago

Avinger, Inc. (AVGR) Q2 2023 Earnings Call Transcript

Jul 27, 2023, 4:01 PM EDT - 1 year ago

Avinger Reports Second Quarter 2023 Results

Jul 20, 2023, 8:00 AM EDT - 1 year ago

Avinger to Announce Second Quarter 2023 Results on July 27

Jun 20, 2023, 8:00 AM EDT - 1 year ago

Avinger Announces Presentations by Key Opinion Leaders at LINC 2023

Jun 9, 2023, 8:00 AM EDT - 1 year ago

Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference

Jun 7, 2023, 8:00 AM EDT - 1 year ago

Avinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System

Jun 5, 2023, 8:00 AM EDT - 1 year ago

Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device

May 10, 2023, 8:38 PM EDT - 1 year ago

Avinger, Inc. (AVGR) Q1 2023 Earnings Call Transcript

May 10, 2023, 4:01 PM EDT - 1 year ago

Avinger Reports First Quarter 2023 Results

May 2, 2023, 8:00 AM EDT - 1 year ago

Avinger to Announce First Quarter 2023 Results on May 10

Apr 28, 2023, 8:00 AM EDT - 1 year ago

Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium

Apr 26, 2023, 8:00 AM EDT - 1 year ago

Avinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System

Mar 15, 2023, 9:15 PM EDT - 2 years ago

Avinger, Inc (AVGR) Q4 2022 Earnings Call Transcript

Mar 15, 2023, 4:01 PM EDT - 2 years ago

Avinger Reports Fourth Quarter 2022 Results

Mar 2, 2023, 8:00 AM EST - 2 years ago

Avinger to Announce Fourth Quarter 2022 Results on March 15

Jan 11, 2023, 8:15 AM EST - 2 years ago

Avinger Announces 510(k) Filing of Pantheris LV

Nov 13, 2022, 12:11 PM EST - 2 years ago

Avinger, Inc (AVGR) Q3 2022 Earnings Call Transcript

Nov 9, 2022, 4:01 PM EST - 2 years ago

Avinger Reports Third Quarter 2022 Results

Nov 4, 2022, 8:00 AM EDT - 2 years ago

Avinger Announces Issuance of Seven New Patents Expanding Coverage for Its Proprietary Image-Guided Atherectomy Devices

Nov 1, 2022, 7:45 AM EDT - 2 years ago

Market Cap	1.95M
Revenue (ttm)	7.65M
Net Income (ttm)	-18.32M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-239.48%
Debt to Equity Ratio	1.07

Volume	196,000
Avg Vol	2,789,502
Day's Range	N/A - N/A
Shares Out	3.31M
Stochastic %K	28%
Beta	1.15
Analysts	Strong Sell
Price Target	$5.00